SP-A exhibits functional and quantitative differences that are influenced by the unique SP-A haplotype, sex, and age of an individual, which ultimately influences health outcomes following infection due to transcriptomic and proteomic differences (46, 47, 84). The gene discussed is SFTPA2; the disease is infection.